Heart rate-lowering therapy in gout patients with stable coronary artery disease: focus on ivabradine
Aim. To study the effect of ivabradine and bisoprolol on cardiac hemodynamics and diastolic remodeling in gout patients with coronary artery disease and hypertension and without left ventricular systolic dysfunction.Material and methods. The open randomized parallel clinical trial of 35 men with int...
Saved in:
| Main Authors: | N. N. Kushnarenko, T. A. Medvedeva, M. Yu. Mishko, T. M. Karavaeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2020-08-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/3980 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heart rate-reducing agents ivabradine and beta-adrenoblockers in the management of patients with stable effort angina
by: Z. M. Galeeva, et al.
Published: (2011-02-01) -
Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
by: K. G. Adamyan, et al.
Published: (2015-11-01) -
Effectiveness of a selective If channel inhibitor ivabradine in patients with stable angina
by: E. V. Kuleshova
Published: (2009-10-01) -
EFFICACY AND SAFETY OF IVABRADINE AND BISOPROLOL IN PATIENTS WITH ISCHEMIC HEART DISEASE: RESULTS OF COMPARATIVE RANDOMIZED OPEN STUDY
by: R. D. Kurbanov, et al.
Published: (2016-01-01) -
Clinical and pathogenetic significance of angiogenesis factors (VEGF-A, HGF, IGF-1) in the development of cardiometabolic disorders in gout patients having different obesity phenotypes
by: T. A. Medvedeva, et al.
Published: (2021-04-01)